Get the latest updates as we post them — right on your browser

. Last Updated: 07/27/2016

Marshall Loses 36.6 Interest

Marshall Capital Partners, a private-equity firm, said Tuesday that it would not buy a stake in Pharmacy Chain 36.6 after regulatory changes made such a transaction “uninteresting.”

Marshall withdrew from talks in “late summer” as “anticipated regulatory changes made such a deal uninteresting for us,” senior managing director Dmitry Kushayev said.